HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts HQY Hot Sheet
Price: $92.61 --0%
Rating Summary:
22 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 23
Rating Summary:
22 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 23
Join SI Premium – FREE
Chardan Capital Markets raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $77.00 (from $62.00) while maintaining a Buy rating.
Analyst Steven Wardell comments "We liked the strong demand we are seeing from the marketplace and strong execution from Management. We raise our PT at $77 based on earnings growth through FY21E and multiple expansion that will bring HQY's valuation to a slight premium over its peers."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Slide Insurance Holdings (SLDE) PT Raised to $28 at Citizens
- Goosehead Insurance Inc. (GSHD) PT Lowered to $80 at Citizens
- JPMorgan Upgrades Manila Electric Co. (MER:PM) (MAEOY) to Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Earnings, Chardan Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
